載入...
Tocilizumab in early progressive rheumatoid arthritis: FUNCTION, a randomised controlled trial
OBJECTIVES: The efficacy of tocilizumab (TCZ), an anti-interleukin-6 receptor antibody, has not previously been evaluated in a population consisting exclusively of patients with early rheumatoid arthritis (RA). METHODS: In a double-blind randomised controlled trial (FUNCTION), 1162 methotrexate (MTX...
Na minha lista:
| 發表在: | Ann Rheum Dis |
|---|---|
| Main Authors: | , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BMJ Publishing Group
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4893095/ https://ncbi.nlm.nih.gov/pubmed/26511996 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/annrheumdis-2015-207628 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|